Cargando…
FBXO2 modulates STAT3 signaling to regulate proliferation and tumorigenicity of osteosarcoma cells
BACKGROUND: Osteosarcoma (OS) is the most common primary bone malignancy in children and adolescents, and hyperproliferation of cells is a major problem of OS. FBXO2 belongs to the family of F-box proteins, and is a substrate recognition component of the Skp1-Cul1-F-box protein (SCF) E3 ubiquitin li...
Autores principales: | Zhao, Xunming, Guo, Weichun, Zou, Lixue, Hu, Biao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296666/ https://www.ncbi.nlm.nih.gov/pubmed/32549792 http://dx.doi.org/10.1186/s12935-020-01326-4 |
Ejemplares similares
-
Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer
por: Liu, Yaqian, et al.
Publicado: (2021) -
miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1
por: Guo, Xiaodong, et al.
Publicado: (2017) -
BMX-ARHGAP fusion protein maintains the tumorigenicity of gastric cancer stem cells by activating the JAK/STAT3 signaling pathway
por: Xu, Xiao-Feng, et al.
Publicado: (2019) -
TIAM2 promotes proliferation and invasion of osteosarcoma cells by activating the JAK2/STAT3 signaling pathway
por: Cheng, Shaohua, et al.
Publicado: (2022) -
Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1/STAT pathway in prostate cancer
por: Rong, Jiping, et al.
Publicado: (2020)